Biomarkers alone don’t mean Alzheimer’s disease is present, Elizabeth Tracey reports

from Johns Hopkins Medicine · host Johns Hopkins Medicine

Will an FDA cleared blood test for Alzheimer’s disease ease or complicate diagnosis? Clearly in approving the test the FDA hopes for the former, yet the complete picture is more complex than that, says Abhay Moghekar, a blood biomarkers expert … Biomarkers alone don’t mean Alzheimer’s disease is present, Elizabeth Tracey reports Read More »

Episode metadata supplied by the publisher feed · Published Jun 9, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Biomarkers alone don’t mean Alzheimer’s disease is present, Elizabeth Tracey reports

0:00 1:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Johns Hopkins Medicine?

This episode is 1 minute long.

When was this Johns Hopkins Medicine episode published?

This episode was published on June 9, 2025.

Can I download this Johns Hopkins Medicine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!